4.2 Article

Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo

Related references

Note: Only part of the references are listed.
Article Immunology

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan

Nobuaki Matsunaga et al.

Summary: This study in Japan examined hospitalized patients with COVID-19, finding that they are typically middle-aged males with close contact to confirmed or suspected cases. The most common comorbidities were hypertension and diabetes. Most patients admitted were nonsevere cases, with a majority not requiring oxygen support during hospitalization.

CLINICAL INFECTIOUS DISEASES (2021)

Article Biochemistry & Molecular Biology

Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

Nicolas Hoertel et al.

Summary: This study suggests that the use of antidepressants in patients hospitalized for COVID-19 may be associated with a lower risk of death or intubation. Antidepressants such as fluoxetine, paroxetine, escitalopram, venlafaxine, and mirtazapine showed significant associations with reduced risk. Further research in the form of double-blind controlled randomized clinical trials is recommended.

MOLECULAR PSYCHIATRY (2021)

Article Medicine, General & Internal

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan

Mari Terada et al.

Summary: This study aimed to investigate the risk factors contributing to severity on admission, worst severity, and fatality in COVID-19 patients. Results showed that older age, male gender, cardiovascular disease, chronic respiratory disease, diabetes, obesity, and hypertension were risk factors for severity on admission. Additionally, risk factors varied when considering worst severity and fatality.

BMJ OPEN (2021)

Review Psychiatry

Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis

Benedetta Vai et al.

Summary: This systematic review and meta-analysis found that pre-existing mental disorders, specifically psychotic and mood disorders, and exposure to antipsychotics and anxiolytics were associated with an increased risk of COVID-19 mortality. The study highlighted the need for targeted approaches to manage and prevent COVID-19 in at-risk patient groups identified in this study. Further research is needed to determine the underlying mechanisms of these associations.

LANCET PSYCHIATRY (2021)